| CRINETICS PHARM. DL-,001 |
| USA |
| Gesundheit |
| US22663K1079 / A2JQTJ |
| 6Z4 (Frankfurt) / CRNX (NASDAQ) |
| FRA:6Z4, ETR:6Z4, 6Z4:GR, NASDAQ:CRNX |
| - |
| https://www.crinetics.com.. |
|
Crinetics Pharmaceuticals Inc. is a biopharmaceuti..
>Volltext.. |
| 3910.66 Mio. EUR |
| 3019.06 Mio. EUR |
| 1.31 Mio. EUR |
| -405.59 Mio. EUR |
| -361.9 Mio. EUR |
| -3.88 EUR |
| 42.04 Mio. EUR |
| 95.29 Mio. EUR |
| -299.12 Mio. EUR |
| 14.74 |
| - |
| -44.45% |
| - |
| - |
| - |
| CRINETICS |
| 08.01.26 |
|